PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
Alzheimer’s saliva test a potential breakthrough, but caution needed
More research has been urged after the creator of a breakthrough test for detecting Alzheimer’s disease said the test could be combined with daily...
Supporting palliative care patients and carers in rural and remote areas
Training carers in symptom management for palliative care patients can help them to achieve their goal to be cared for and die at home,...
New ECP Director to focus on the future
WA-based hospital pharmacist Lauren Burton has been appointed as the new Early Career Pharmacist (ECP) Director of PSA, effective from 1 July 2018.
PSA...
Cost savings from pharmacist-led post-discharge care
US research has found pharmacist-led post-discharge care for high-risk patients resulted in fewer admissions and healthcare cost savings of more than $US500 per patient.
In...
Study identifies predisposition to opioid dependence
As the fatal consequences of prescription overdoses have climbed in Australia, a recently published study from Monash University identified key factors that could indicate...
